2018
DOI: 10.1371/journal.pone.0200855
|View full text |Cite
|
Sign up to set email alerts
|

Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis

Abstract: Background and aimsExpression of carbonic anhydrase IX (CA9), an enzyme expressed in response to hypoxia, acidosis and oncogenic alterations, is reported to be a prognostic factor in HCC patients. Here we evaluated serum CA9 levels in HCC and cirrhosis patients.MethodsHCC and cirrhosis patients were prospectively recruited and CA9 levels were determined. CA9 levels were compared to stages of cirrhosis and HCC stages. The association of the CA9 levels and overall survival (OS) was assessed. Furthermore, immunoh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(15 citation statements)
references
References 35 publications
3
12
0
Order By: Relevance
“…By comparing the gene expression profiling between the two subtypes, we found that the aggressive Cluster2 tumors had significantly upregulated expression of stemness-related genes such as CA9, EpCAM, MMP9, KRT19, CD24, and PROM1 (CD133). These are well-known markers of stemness traits and are associated with poorer prognostic outcomes in HCC [18,[59][60][61][62]. Based on integrative analysis of genomic and epigenomic data in liver cancer, Woo et al also identified one aggressive cluster of the HCC subtype (iCl1) with the previously mentioned stemness-related genes being on top of the upregulated genes [17], which is similar to our finding.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…By comparing the gene expression profiling between the two subtypes, we found that the aggressive Cluster2 tumors had significantly upregulated expression of stemness-related genes such as CA9, EpCAM, MMP9, KRT19, CD24, and PROM1 (CD133). These are well-known markers of stemness traits and are associated with poorer prognostic outcomes in HCC [18,[59][60][61][62]. Based on integrative analysis of genomic and epigenomic data in liver cancer, Woo et al also identified one aggressive cluster of the HCC subtype (iCl1) with the previously mentioned stemness-related genes being on top of the upregulated genes [17], which is similar to our finding.…”
Section: Discussionsupporting
confidence: 90%
“…Similar to the findings of Woo et al [17], we found that CA9 was the most upregulated gene in Cluster2 of TCGA data with more than a 20-fold difference ( Figure 7A). As a marker of hypoxia, overexpression of CA9 is a poor prognostic marker in HCC, and its expression is associated with stemness-related phenotypes in HCC [17,18]. Our results also showed that increased CA9 expression was significantly associated with a poor prognosis of OS (p = 0.0002, HR: 1.085 with 95% CI (1.04, 1.132)).…”
Section: Identification Of Genomic Key Features In the Hcc Subtypessupporting
confidence: 68%
“…AFP expression mainly occurs in fetal liver cells, and although AFP disappears from the blood about 2 weeks after birth, its overexpression can be detected in liver cancer patients. As a marker of hypoxia, CA9 is also a marker for poor prognosis in HCC, and recent studies show that its expression is related to stem cell phenotypes (44,45). This indicates that molecular subtype C2 may be related to stem cell characteristics.…”
Section: Discussionmentioning
confidence: 99%
“…Tumorigenic signaling and induced tumor hypoxia in mal-perfused regions of tumors are main features of tumorigenesis. The expression of oncogenic CAs such as CA IX or CA XII is enhanced in hypoxic regions [85][86][87][88][89][90][91]. These enzymes help to maintain an acidic environment and produce HCO3 − to serve HCO3 − transporters.…”
Section: Tumor Systemmentioning
confidence: 99%